期刊文献+

MARCH8在宫颈癌组织中的表达及其沉默后对人宫颈癌细胞增殖、凋亡的影响 被引量:2

Expression of MARCH8 in cervical cancer tissues and effects of silencing on proliferation and apoptosis of human cervical cancer cells
下载PDF
导出
摘要 目的探索MARCH8表达量对宫颈癌的影响以及MARCH8沉默后宫颈癌细胞增殖、凋亡的影响,并对其可能存在的机制进行研究。方法选取我院宫颈癌手术切除标本20份作为研究对象,同时选取20例正常宫颈组织人群作为对照。免疫组化检测宫颈癌组织MARCH8表达水平;构建MARCH8的siRNA片段通过脂质体介导转染人宫颈癌Hela细胞(MARCH8-RNAi),Western blot与RT-PCR进行检测验证;MTT法检测MARCH8-RNAi细胞增值率、FCM法检测细胞周期及细胞凋亡率,Hoechst 33342检测凋亡小体形成情况,免疫组化及Western blot检测细胞周期、荧光定量PCR检测凋亡相关蛋白表达水平。结果免疫组化结果显示宫颈癌组织中MARCH8阳性表达率高于正常宫颈组织(P<0.01);Western blot与RT-PCR结果显示MARCH8-RNAi细胞中MARCH8表达量显著低于Ctrl(P<0.01);MARCH8-RNAi细胞增殖率及存活率均降低、处于G 0/G 1期细胞增多、PCNA、CDK2、CyclinD1表达水平降低,与Ctrl差异有统计学意义(P<0.01);FCM及Hoechst 33342结果显示MARCH8-RNAi细胞凋亡率升高、凋亡小体数目增加,Ki67、Bcl-2蛋白水平降低,而Caspase-3、Bax、P53蛋白表达量增加与Ctrl差异有统计学意义(P<0.01)。结论MARCH8在宫颈癌中高表达且MARCH8沉默后可通过调节细胞周期、凋亡相关基因蛋白水平抑制人宫颈癌Hela细胞增殖、促进细胞凋亡。 Objective To observe the expression of MARCH8 in cervical cancer,explore the effects on the proliferation and apoptosis of cervical cancer cells after MARCH8 silencing,and study the possible mechanism.Methods Twenty samples of cervical cancer obtained from resection in our hospital were selected as the research subjects,and 20 normal cervical tissues were selected as the controls.Immunohistochemistry was used to detect the level of MARCH8 in cervical cancer tissues.The siRNA fragments of MARCH8 were constructed and transfected into human cervical cancer Hela cells(MARCH8-RNAi)via liposomes.Western blot and RT-PCR were used to verify the results.MTT was used to detect MARCH8-RNAi cell proliferation rate,FCM method was used to detect cell cycle distribution and apoptotic rate,Hoechst 33342 was used to detect apoptotic body formation,immunohistochemistry and Western blot were used to detect the apoptosis-related protein levels,and RT-PCR was used to detect the cell cycle-related gene expressions.Results The immunohistochemical results showed that the expression of MARCH8 in cervical cancer tissues was higher than that in normal cervical tissues(P<0.01).Western blot and RT-PCR results showed that the expression of MARCH8 in MARCH8-RNAi cells was significantly lower than that in the control cells(P<0.01).MARCH8-RNAi cells had reduced proliferation and survival rates,increased G 0/G 1 cells,and decreased PCNA,CDK2,and CyclinD1 gene expressions,and the differences with the control cells were statistically significant(P<0.01).FCM and Hoechst 33342 results showed MARCH8-RNAi cell apoptosis rate was increased,the number of apoptotic bodies was increased,Ki67,Bcl-2 protein levels were decreased,while Caspase-3,Bax,P53 protein levels were increased significantly(P<0.01).Conclusion MARCH8 is highly expressed in cervical cancer and its silencing can inhibit the proliferation and promote the apoptosis of human cervical cancer Hela cells by regulating cell cycle and apoptosis-related gene or protein levels.
作者 税成愈 向灿 Shui Chengyu;Xiang Can(Department of Obstetrics and Gynecology,Department of Western Medicine,Enshi Central Hospital,Enshi Hubei 445000,China;Department of Obstetrics and Gynecology,Tongji Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology,Wuhan Hubei 430000,China)
出处 《遵义医科大学学报》 2020年第1期69-75,共7页 Journal of Zunyi Medical University
基金 湖北省自然科学基金资助项目(NO:2014CFC1066)。
关键词 宫颈癌 MARCH8 基因沉默 细胞增殖 细胞凋亡 cervical cancer MARCH8 gene silencing cell proliferation apoptosis
  • 相关文献

参考文献3

二级参考文献15

  • 1Annahita, Mehrazma, Alireza, et al. Immunohistochemical staining expression of Ki67 protein in canine mammary gland carcinoma[J]. Compare clinical pathology, 2011,20 (6) : 557- 561. DOI 10. 1007/s00580-010-1032 3.
  • 2Brown D C, Garter K C. Monoclonal antibody Ki-67~ its use in histopathology[J]. Histopathology, 1990. 17(6): 489- 503.
  • 3Allred D C; Harvey J M, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical a nalvsis[J]. Modern oatholo~y, 1998, 11(2): 155.
  • 4Amin M B, Ma C K, Linden M D,et al. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors[J]. American journal of clinical pathology, 1993, 100 (4) : 428-432.
  • 5Van Diest P J, Brugal G, Baak J P. Proliferation markers in tumours: interpretation and clinical value[J]. Journal of clini cal pathologyX, 1998, 51(10): 716 -724.
  • 6Shivji K K. Proliferating cell nuclear antigen is required for DNA excision repair[J]. Cell, 1992, 69(2) : 367.
  • 7Leonardi E, Girlando S, Serio G, et al. PCNA and Ki67 ex pression in breast carcinoma~ correlations with clinical and bio- logical variables[J]. J Clin Pathol, 2002,45 : 416-419.
  • 8Preziosi R, Sarli G, Benazzi C., etal. Detection of prolifera- ting cell nuclear antigen (PCNA) in canine and feline mamma ry tumors[J]. J Comp Pathol, 2004,16:542-547.
  • 9Madewell B R. Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications[J]. J Vet Intern Med, 2001,15 : 334-340.
  • 10Laura P, Kyles A E, Farver T B, et al. Indicators of malig- nancy of canine adrenocortical tumors: histopathology and pro- liferation index[J]. Vet Pathol,2004, 41(5):490-497.

共引文献269

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部